We searched the Cochrane Library, Medline, and Embase (date last accessed March 15, 2013) with the terms: “autoimmunity”, “T cell”, “B cell”, “regulatory”, “Th1”, “Th2”, “Th17”, “autoantibodies”, “dendritic cell”, “lymphoid organs”, “germinal centers”, “follicles”, “cytokines”, “organ damage”, “lupus”, “autoimmune myositis”, “dermatomyositis”, “Sjögren”, and “co-stimulation” in different combinations. Because of the comprehensive topic, we selected the most relevant publications from the
SeriesImmunopathogenic mechanisms of systemic autoimmune disease
Introduction
Our immune system developed to protect us against invading pathogens and to aid tissue healing after injury. In systemic autoimmune diseases, mechanisms that regulate the balance between recognition of pathogens and avoidance of self-attack are impaired. Furthermore, control of inflammation is lost, resulting in continuous immune activation without any overt infection, with different amplitudes during flares and quiescent disease. Adaptive immunity providing immune memory remains of central interest, but the role of the innate immune system in the pathogenesis of systemic autoimmunity is also currently under intense investigation. Study findings suggest genetic risk loci are shared in systemic autoimmune diseases and, therefore, that pathogenic mechanisms may be similar.1 However, distinct loci have also been identified that are specific to individual diseases, indicating that various immunopathogenic pathways are present.2 Concordance rates of 20–30% in monozygotic twins emphasise that environmental components that interact with the host genetic factors are important to our understanding of autoimmunity.
Two hypotheses for systemic autoimmune inflammation have been suggested. First, barrier control between innate and adaptive immunity could be disturbed, fuelling continuous inflammation by a positive feedforward loop, consistent with interferon effects. Second, impaired reactivity of adaptive immunity with reactivated (auto)reactive memory by lymphocytes could result in persistent inflammation and include defects of tolerance checkpoints. These two ideas are not mutually exclusive, and both innate and adaptive mechanisms seem operational in systemic autoimmunity.
Systemic lupus erythematosus, Sjögren's syndrome, and dermatomyositis are systemic autoimmune diseases that share clinical, immunological, and genetic features but have disease-specific traits. In people with systemic lupus erythematosus, almost any organ of the body could be a target for autoimmune inflammation, whereas Sjögren's syndrome is restricted mostly to exocrine glands; in dermatomyositis, proximal muscles and skin are affected predominantly. In this Review, we describe our current understanding of the immunopathogenic mechanisms underlying systemic autoimmunity, with particular reference to systemic lupus erythematosus, Sjögren's syndrome, and dermatomyositis.
Section snippets
Induction of autoimmunity
The idea that we are predisposed genetically to either an increased or diminished risk of developing systemic autoimmunity stems from observations of disease prevalence within families and in the general population. Most autoimmune disorders have a frequency in the general population of 0·1–1·0%, whereas prevalence in first-degree relatives is around five times higher, with a further five times increase in monozygotic twins of affected individuals. Although risk is obviously raised with
The innate system in systemic autoimmunity
The innate immune system—consisting of physical mucosal barriers, proteins, and cells such as granulocytes, natural killer cells, macrophages, and dendritic cells—serves as the front line against infectious agents and other environmental challenges. Dendritic cell homoeostasis is implicated directly in systemic autoimmunity, and dendritic cells contribute to disease both as antigen presenters and as major producers of type 1 interferon.21 Different subsets of dendritic cells regulate humoral
Directing role of cytokines in T-cell differentiation
T-cell abnormalities have been detected in autoimmunity, but whether these aberrations represent primary deviations or reflect a response to exogenous effects by cytokines produced by an impaired immune system is uncertain. Naive CD4+ T cells differentiate into subsets of effector T-helper cells after activation and costimulation, a process controlled by specific cytokines (figure 3). T-helper-1 cell differentiation is promoted by interleukin 12 and interferon γ, T-helper-2 cells depend on
Role of target tissue in autoimmune disease development
Interactions between organ tissue and the immune system are important to establish the degree of autoreactivity (panel 1). Organs serve as direct autoimmune targets and provide the microenvironment for induction and maintenance of ectopic immune responses, which further propagate tissue damage and dysfunction.
Considerations for therapeutic development and future directions
Targeting central molecules in upstream regulatory checkpoints in initiation of the inflammatory cascade, before all downstream pathways have been activated, has been suggested as a potentially effective strategy for treatment of systemic autoimmune diseases. However, the effectiveness of targeted treatments is hard to predict. Although not the primary factor in regulation of inflammation, tumour necrosis factor α has proved a target for amelioration of joint-related autoimmune diseases. When
Search strategy and selection criteria
References (103)
- et al.
Drugs and autoimmunity: a contemporary review and mechanistic approach
J Autoimmun
(2010) - et al.
Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study
Blood
(2012) - et al.
Type I interferon in systemic lupus erythematosus and other autoimmune diseases
Immunity
(2006) - et al.
Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus
Am J Hum Genet
(2005) - et al.
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6
Immunity
(2003) - et al.
Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease
Immunity
(2012) - et al.
Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity
Clin Immunol
(2008) - et al.
Identification of regulatory T cells in systemic lupus erythematosus
Autoimmun Rev
(2009) - et al.
Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion
Immunity
(2011) - et al.
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Blood
(2011)
B-cell tolerance checkpoints in health and autoimmunity
Curr Opin Immunol
Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system
Blood
New treatments for SLE: cell-depleting and anti-cytokine therapies
Best Pract Res Clin Rheumatol
Tertiary lymphoid organs in infection and autoimmunity
Trends Immunol
The dynamic structure of the germinal center
Immunol Today
Clearance deficiency and systemic lupus erythematosus (SLE)
J Autoimmun
Detecting shared pathogenesis from the shared genetics of immune-related diseases
Nat Rev Genet
Genomics and the multifactorial nature of human autoimmune disease
N Engl J Med
The complex role of estrogens in inflammation
Endocrine Rev
Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE
Eur J Hum Genet
Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes
PLoS Genet
HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy
Rheumatology
In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response
Arthritis Rheum
Genetics of systemic lupus erythematosus and Sjögren's syndrome
Curr Opin Rheumatol
Genetic susceptibility to systemic lupus erythematosus in the genomic era
Nat Rev Rheumatol
A genome-wide association study establishes muliple susceptibility loci for Sjogren's syndrome
Arthritis Rheum
Genome-wide association study of dermatomyositis reveals shared genetic risk factors with other autoimmune diseases
Arthritis Rheum
A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
Hum Mol Genet
Prevention of autoimmune rheumatic disease: state of the art and future perspectives
Ann Rheum Dis
Recent advances in the immunogenetics of idiopathic inflammatory myopathy
Arthritis Res Ther
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
N Engl J Med
Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden
Arthritis Res Ther
Long-term outcome of mothers of children with isolated heart block in Finland
Arthritis Rheum
Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case-control study
Ann Rheum Dis
The innate immune system in SLE: type I interferons and dendritic cells
Lupus
Cancer immunotherapy via dendritic cells
Nat Rev Cancer
Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors
Ann Intern Med
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome
Proc Natl Acad Sci USA
Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis
Ann Neurol
Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus
Lupus
Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism
Arthritis Rheum
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
Proc Natl Acad Sci USA
NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus
Sci Transl Med
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus
N Engl J Med
Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus
Science
HLA-DRhigh/CD27(high) plasmablasts indicate active disease in patients with systemic lupus erythematosus
Ann Rheum Dis
Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus
J Immunol
Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus
Arthritis Rheum
Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus
J Clin Invest
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
Nat Rev Rheumatol
Cited by (419)
Emerging strategies for nanomedicine in autoimmunity
2024, Advanced Drug Delivery ReviewsMachine learning application in autoimmune diseases: State of art and future prospectives
2024, Autoimmunity ReviewsB cell activation and autoantibody production in autoimmune diseases
2024, Best Practice and Research: Clinical RheumatologyRole of the Hippo pathway in autoimmune diseases
2024, Experimental Gerontology